FDA
-
-
-
-
-
-
-
Neoleukin Therapeutics Announces Clearance to Proceed with NL-201 Phase 1 Clinical Trial in the United States
-
-
-
-
-
-
-
Neoleukin Therapeutics Receives Clinical Hold Letter from U.S. FDA Related to CMC Assay Development for NL-201
-
-
-
-
-
-
-
After-Hours Stock Movers 7/1: (VERO) (NUS) (FORM) Higher; (CULP) (ZOM) (BLFS) Lower (more...)
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

